Mutation, detection, prenatal testing, and delineation of the germline origin in a family with sporadic hemophilia B and no living hemophiliacs

Journal Article · Sat Jan 15 00:00:00 EST 1994 · American Journal of Medical Genetics

DOI:https://doi.org/10.1002/ajmg.1320490223· OSTI ID:96034

Vielhaber, E; Sommer, S S ^[1]; Freedenberg, D ^[2]

---

1. Mayo Clinic/Foundation, Rochester, MN (United States)
2. Scott and White Clinic, Temple, TX (United States)

Hemophilia B is an X-linked recessive disorder affecting 1 in 30,000 males. Determination of carrier status for at risk females can be done by utilizing indirect methods such as DNA sequencing. However, in most cases, reliable carrier testing is not possible without first analyzing the DNA from an affected male in the family to determine his haplotype/causative sequence change. In the case presented here, the only affected male in the family has been deceased for 25 years; no DNA was available from him. The sister (III-2) of the affected individual was a suspected carrier based on her factor IX coagulant (36%); she was pregnant with a male fetus, and requested prenatal testing. 6 refs., 2 figs.

• Sponsoring Organization: USDOE
• OSTI ID: 96034
• Journal Information: American Journal of Medical Genetics, Vol. 49, Issue 2; Other Information: PBD: 15 Jan 1994
• Country of Publication: United States
• Language: English

Related Subjects

55 BIOLOGY AND MEDICINE
BASIC STUDIES
HEMOPHILIA
DIAGNOSTIC TECHNIQUES
GENE MUTATIONS
DETECTION
GENES
DNA SEQUENCING